The Magazine for Sleep Professionals
Wednesday, September 9, 2026
EnsoData Raises $20M to Accelerate Commercialization of AI-powered Sleep Solutions EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in […]
EnsoData has announced a collaboration with Takeda to jointly develop and validate AI-based polysomnography (PSG) algorithms to support more accurate and scalable diagnosis of narcolepsy type 1 (NT1). Upon successful validation and regulatory clearance, EnsoData will pursue the clinical availability and release of AI algorithms to enable future access, use, […]
EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in the US alone, an estimated 54 million patients suffering from […]
EnsoData, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO). Cockrill will oversee strategy and execution of sales and marketing functions and continue accelerating EnsoSleep PPG™, EnsoSleep™, RPM, and EnsoTherapy™ adoption across North America. Cockrill comes from Bardy Diagnostics (BDx), where he […]
EnsoData, a leader in healthcare AI technology, is partnering with Advanced Brain Monitoring (ABM) to add position data captured by ABM’s Night Shift sleep positioner into the FDA-cleared EnsoSleep PPG home sleep test (HST). Adding positional data to EnsoSleep PPG offers providers accurate supine AHI severity insights, leading to better […]
EnsoData, an innovator in AI healthtech solutions, is proud to introduce a new RPM (remote physiological monitoring) offering to the EnsoSleep PPG ecosystem of AI tools. EnsoData’s RPM solution allows clinicians to seamlessly monitor patients over time and proactively intervene when patients need support with their therapy the most. RPM […]
Sleep apnea is a growing health concern in the United States, affecting approximately 54 million Americans, with 80% of cases remaining undiagnosed. This widespread issue continues to contribute to serious health problems, including cardiovascular disease, stroke, diabetes, and depression. As the U.S. population ages and the obesity epidemic persists, the […]
EnsoData, an innovator in AI healthtech solutions, is enhancing the FDA-cleared EnsoSleep PPG home sleep apnea testing (HSAT) solution by integrating three new physical channels. These channels provide additional physiological data to support sleep clinicians in diagnosing and treating sleep disorders using FDA-cleared pulse oximeters. EnsoData introduces all three channels […]
BodiMetrics, a leader in well-being and fitness monitoring devices, announces a partnership with EnsoData, a pioneer in healthcare AI, to power BodiMetrics’ FDA-cleared circul pro™ smart ring with the FDA-cleared EnsoSleep PPG software as a medical device (SaMD) to increase affordability and accessibility of home sleep apnea testing and longitudinal […]
EnsoData and HappyHealth, manufacturers of the Happy Ring, announce a partnership to meet the growing demand for simple, clinical-grade nightly sleep monitoring in the home. Happy Health’s platform, Happy Sleep, allows patients to directly receive an FDA-approved sleep test powered by EnsoSleep PPG, see a board-certified sleep doctor, and begin […]
